000 | 01922 a2200529 4500 | ||
---|---|---|---|
005 | 20250513213935.0 | ||
264 | 0 | _c20001019 | |
008 | 200010s 0 0 fre d | ||
022 | _a0035-3787 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVinciguerra, C | |
245 | 0 | 0 |
_a[Postoperative combined medullary sclerosis revealing Biermer's disease: toxic effect of nitrous oxide]. _h[electronic resource] |
260 |
_bRevue neurologique _cJul 2000 |
||
300 |
_a665-7 p. _bdigital |
||
500 | _aPublication Type: Case Reports; English Abstract; Journal Article; Review | ||
650 | 0 | 4 |
_a5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase _xantagonists & inhibitors |
650 | 0 | 4 |
_aAbscess _xsurgery |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnemia, Pernicious _xcomplications |
650 | 0 | 4 |
_aAnesthetics, Inhalation _xadverse effects |
650 | 0 | 4 | _aArthroplasty, Replacement, Hip |
650 | 0 | 4 | _aAtrophy |
650 | 0 | 4 |
_aAutoantibodies _xblood |
650 | 0 | 4 |
_aAutoimmune Diseases _xcomplications |
650 | 0 | 4 |
_aDemyelinating Diseases _xchemically induced |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGastric Mucosa _xpathology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntestinal Absorption |
650 | 0 | 4 |
_aIntrinsic Factor _ximmunology |
650 | 0 | 4 |
_aNitrous Oxide _xadverse effects |
650 | 0 | 4 | _aOxidation-Reduction |
650 | 0 | 4 |
_aParesthesia _xchemically induced |
650 | 0 | 4 |
_aPostoperative Complications _xchemically induced |
650 | 0 | 4 |
_aProprioception _xphysiology |
650 | 0 | 4 |
_aS-Adenosylmethionine _xdeficiency |
650 | 0 | 4 | _aSclerosis |
650 | 0 | 4 |
_aSpinal Cord _xpathology |
650 | 0 | 4 |
_aSpinal Cord Diseases _xchemically induced |
650 | 0 | 4 |
_aSurgical Wound Infection _xsurgery |
650 | 0 | 4 |
_aVitamin B 12 _xantagonists & inhibitors |
700 | 1 | _aChazerain, P | |
700 | 1 | _aOlivero de Rubiana, J P | |
700 | 1 | _aMoulonguet, A | |
700 | 1 | _aZiza, J M | |
773 | 0 |
_tRevue neurologique _gvol. 156 _gno. 6-7 _gp. 665-7 |
|
999 |
_c10842212 _d10842212 |